Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

0.3342 -0.0171 (-4.87%)

Streaming Delayed Price Updated: 1:03 PM EDT, Apr 20, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,371,831
Open	0.3398
Bid (Size)	0.3340 (500)
Ask (Size)	0.3379 (500)
Prev. Close	0.3513
Today's Range	0.3176 - 0.3422
52wk Range	0.2899 - 8.940
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics

April 18, 2026

Via ACCESS Newswire

Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome

April 17, 2026

Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinoma

From Medicus Pharma Ltd

Via GlobeNewswire

Performance

YTD	-79.1%	-79.1%
1 Month	-34.3%	-34.3%
3 Month	-75.6%	-75.6%
6 Month	-86.6%	-86.6%
1 Year	-91.8%	-91.8%

More News

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression

April 15, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)

April 11, 2026

Via ACCESS Newswire

New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms

April 07, 2026

Via ACCESS Newswire

Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention

April 06, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

April 01, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate

March 30, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Medicus Pharma (MDCX): A Small-Cap Biotech Making Moves in 2026

March 27, 2026

Via AB Newswire

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

March 26, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update

March 25, 2026

Via ACCESS Newswire

Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

March 18, 2026

Via ACCESS Newswire

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

March 16, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST

March 14, 2026

Via ACCESS Newswire

Unusual volume stocks in Tuesday's session ↗

March 10, 2026

Via Chartmill

Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum

March 10, 2026

Via ACCESS Newswire

These stocks are making the most noise in today's session. ↗

March 09, 2026

Via Chartmill

American Lithium Minerals (OTC: AMLM) Targets Tokenized Commodities Opportunity Alongside MDCX, ASNS, EONR, ELPW Today!

March 09, 2026

Via AB Newswire

Monday's session: top gainers and losers ↗

March 09, 2026

Via Chartmill

Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset

March 09, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA

March 07, 2026

Via ACCESS Newswire

Here are the top movers in Friday's session. ↗

March 06, 2026

Via Chartmill

Which stocks are moving on Friday? ↗

March 06, 2026

Via Chartmill

The market is filled with gapping stocks in Friday's session. ↗

March 06, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Thursday's session. ↗

March 05, 2026

Via Chartmill

Frequently Asked Questions

Is Medicus Pharma Ltd. - Common Stock publicly traded?

Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.

What exchange does Medicus Pharma Ltd. - Common Stock trade on?

Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?

The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market

What is the current price of Medicus Pharma Ltd. - Common Stock?

The current price of Medicus Pharma Ltd. - Common Stock is 0.3342

When was Medicus Pharma Ltd. - Common Stock last traded?

The last trade of Medicus Pharma Ltd. - Common Stock was at 04/20/26 01:03 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.